Norges Bank’s Evogene EVGN Stock Holding History

Norges Bank’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23	Closed	–	–	2097
2019 Q2	$0	Sell	23 -626	-96%	-$11.6K	﹤0.01%	2117
2019 Q1	$11K	Hold	649	–	–	﹤0.01%	2113
2018 Q4	$13K	Hold	649	–	–	﹤0.01%	2112
2018 Q3	$20K	Hold	649	–	–	﹤0.01%	2130
2018 Q2	$19K	Hold	649	–	–	﹤0.01%	2122
2018 Q1	$21K	Buy	+649	New	+$24.2K	﹤0.01%	2130

Other funds holding EVGN

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

MCM

Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Norges Bank's EVGN Position: Q3 2019 in Review

Norges Bank sold out of Evogene (EVGN) in Q3 2019, closing a stake of 23 shares.

Norges Bank first reported a position in EVGN in Q1 2018 and held it in 6 quarters. The position peaked at $21K in Q1 2018. 17 funds tracked by Wall St. Rank hold EVGN as of Q3 2019.

Norges Bank reported no remaining Evogene position as of Q3 2019 after selling out during the quarter.
Norges Bank sold 23 Evogene shares in Q3 2019.
Norges Bank first reported a position in Evogene in Q1 2018 and held it in 6 quarters.
Norges Bank's Evogene position peaked at $21K in Q1 2018.
17 funds tracked by Wall St. Rank held Evogene as of Q3 2019.

Based on Norges Bank's 13F filing for Q3 2019, filed 8 Nov 2019.